Issues related to FDA drug approval processes.
2026 · 2nd Quarter (Apr 1 - June 30)
IMMIX BIOPHARMA INC.
Filed by AXADVOCACY GOVERNMENT RELATIONS.
Open official filingSource-reported fields
Filing overview
- Type
- Registration
- Posted
- Jul 7, 2026
- Income
- Not reported
- Expenses
- Not reported
- Registrant
- AXADVOCACY GOVERNMENT RELATIONS
- Client
- IMMIX BIOPHARMA INC.
- Filing UUID
- 1e0ae749-8475-4304-9151-ecffb06fd46d
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.